FDA Clears HoneyNaps Ai Software for Sleep Apnea Analysis
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.
Martha Lillard, who was diagnosed with polio at age 5, passed away at the age of 78 after using an iron lung device for over seven decades.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Integrating genetic and telomere assessments into clinical care helps physicians refine diagnoses and adjust pulmonary fibrosis treatment plans.
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
A 10-year analysis of emergency department data shows one sport poses a greater risk of severe injury to youth athletes.
UT Southwestern Medical Center is the first healthcare provider in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.